GSD1b Session w/ FDA

On March 3rd, 2022 we had the honor of hosting a Patient-Led Listening Session with the United States Food and Drug Administration. These sessions are granted after application from a patient organization, which in this case was Sophie’s Hope Foundation and CureGSD1b. The intent of the session is for rare disease organizations to educate the FDA on the disease and challenges associated with it either as a patient or caregiver. Every office within the FDA was represented and the feedback regarding our session was very encouraging. Below you will find all the material from our session.

FDA Session Summary: Download PDF Here

GSD1b Presentation Slides for the FDA: Download PDF Here